In the Intensive Statin and Antiplatelet Therapy for Acute High-Risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial, Chinese patients with mild ischemic stroke or high-risk transient ischemic
“There are now two evidence-based pathways for the management of stable angina: initiation of medical therapy, followed by more intensive therapy and then [percutaneous coronary
Hyponatremia associated with thiazide diuretics is more common than suggested in product labeling, according to a nationwide study from Denmark. Especially in the early months
In a study of veterans aged 65 years or older, new statin use lowered mortality and major adverse cardiovascular events (MACE) independent of frailty status, researchers
In caring for hospitalized patients with decompensated heart failure (HF), clinicians should apply the major components of treatment: diuresis, optimization of guideline-directed medical therapy (GDMT),
In a Grand Rounds presentation from Beth Israel Deaconess Medical Center, a cardiologist and a geriatrician discuss the diagnosis and management of heart failure with
A population-based cohort study of linked health administrative databases in Ontario shows that older adults had increased serious adverse events (SAEs) when initiation of calcium
The most common sustained arrhythmia, atrial fibrillation (AF), is the focus of a 2023 guideline from the American College of Cardiology (ACC) and American Heart
Compiling data from 7 clinical trials, researchers conclude that the small interfering RNA (siRNA) agent inclisiran was well tolerated during long-term treatment of dyslipidemias in
Data on the clinical use of the oral, direct factor Xa inhibitor apixaban in pediatric patients with heart disease correlated well with experiences in adults,